[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT07723235":3,"trial-entities:NCT07723235":198,"trial-summary:NCT07723235":202},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":7,"overall_status":8,"completion_date":9,"status_verified_date":10,"last_update_date":11,"start_date":12,"sponsor_name":13,"lead_sponsor_class":14,"has_dmc":15,"brief_summary":16,"detailed_description":17,"conditions":18,"keywords":26,"study_type":27,"primary_purpose":28,"phases":29,"enrollment_info":31,"interventions":34,"primary_outcomes":116,"secondary_outcomes":141,"sex":142,"minimum_age":143,"maximum_age":144,"healthy_volunteers":145,"eligibility_criteria":146,"std_ages":166,"locations":169,"central_contacts":186,"overall_officials":191,"references":193,"see_also_links":194},"NCT07723235","OSU-26016","Web-based Lifestyle Program, mHealth and EMA Intervention, to Improve Weight Loss in Rural Stage I-III Postmenopausal Breast and Endometrial Cancer Survivors, HERO-C Trial","Health Engagement for Rural Ohio Cancer Survivors (HERO-C)","NOT_YET_RECRUITING","2027-12-31","2026-07","2026-07-23","2026-10-10","Ohio State University Comprehensive Cancer Center","OTHER",true,"This clinical trial identifies the needs and preferences of rural stage I-III postmenopausal breast and endometrial cancer survivors and evaluates the impact of an adaptive, online program, mobile (m)Health + ecological momentary assessment (EMA) intervention, on lifestyle modification and their weight loss efforts. Obesity, a condition marked by an abnormally high, unhealthy amount of body fat, is associated with lower physical and psychological well-being, higher risk of recurrence, and higher cancer-specific and all-cause mortality (number of deaths). Lifestyle factors, such as low physical activity and unhealthy diet, are the main contributors to obesity that are modifiable. Lifestyle weight loss programs focusing on modifiable factors can improve cancer-specific survival and many aspects of health, but access to these programs can be challenging in rural settings. A remote lifestyle program, adapted to individual goals and needs, may help promote healthy behaviors, improve cancer outcomes, and reduce disease burden in stage I-III postmenopausal breast and endometrial cancer survivors.","PRIMARY OBJECTIVES:\n\nI. To determine the feasibility of an mHealth + EMA intervention in addition to the web-based lifestyle program with remote outcome assessments among rural breast and endometrial cancer survivors. (Aim 1) Ia. To identify rural cancer survivors' perspectives and unique needs\u002Fchallenges of participating in a web-based lifestyle program via focus groups pre- and post-intervention (n=20); (Aim 1a) Ib. To determine the feasibility of mHealth + EMA among early non-responders (week 5-26); (Aim 1b) Ic. To determine the feasibility of remote outcome assessments. (Aim 1c) II. To determine the preliminary efficacy of the additional mHealth + EMA intervention for early non-responders from the web-based lifestyle program (within-person change from week 5-26). (Aim 2)\n\nEXPLORATORY OBJECTIVE:\n\nI. To explore the differences in metabolomic, inflammatory, behavioral, and psychosocial factors between early responders and early non-responders at baseline, month 1 and month 6.\n\nOUTLINE:\n\nPHASE I (WEEKS 1-4): Patients complete self-paced web-based lifestyle program modules over 45-90 minutes weekly for 4 weeks. Patients adhere to a personalized diet meeting American Institute of Cancer Research (AICR) guidelines and receive access to online resources, including AICR resources, online cooking class videos, healthy eating recipes and tips. Patients participate in moderate-intensity aerobic physical activity over 10-30 minutes on 5 days weekly and resistance training over 30 minutes on 2-3 times weekly.\n\nPHASE II (WEEKS 5-26): Patients are assigned to 1 of 2 groups based on Phase I progress.\n\nGROUP I (EARLY RESPONDER): Patients continue web-based program modules, exercise program and diet recommendations as in Phase I. Patients also attend virtual group sessions over 45-50 minutes weekly for weeks 5-26.\n\nGROUP II (EARLY NON-RESPONDER): Patients continue web-based program modules, exercise program and diet recommendations as in Phase I. Patients also set goals for behavioral changes weekly and receive just-in-time adaptive interventions (JITAI) tailored resource components via mHealth + EMA during weeks 5-26. Patients wear a physical activity tracker daily and receive access to the Fitbit application (App).\n\nPatients may also participate in a focus group over 30-45 minutes on study. Additionally, patients undergo urine and blood sample collection throughout the study.\n\nAfter completion of study intervention, patients may follow up in 6 months.",[19,20,21,22,23,24,25],"Anatomic Stage I Breast Cancer AJCC v8","Anatomic Stage II Breast Cancer AJCC v8","Anatomic Stage III Breast Cancer AJCC v8","Endometrial Carcinoma","Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8","Stage II Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8","Stage III Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8",[],"INTERVENTIONAL","SUPPORTIVE_CARE",[30],"NA",{"count":32,"type":33},90,"ESTIMATED",[35,43,53,63,69,73,77,81,85,91,100,108,112],{"type":14,"name":36,"description":37,"armGroupLabels":38,"otherNames":41},"Aerobic Exercise","Participate in moderate-intensity aerobic physical activity",[39,40],"Group I (web-based lifestyle program, virtual group)","Group II (web-based lifestyle, JITAI)",[42],"Aerobic Activity",{"type":44,"name":45,"description":46,"armGroupLabels":47,"otherNames":48},"PROCEDURE","Biospecimen Collection","Undergo urine and blood sample collection",[39,40],[49,50,51,52],"Biological Sample Collection","Biospecimen Collected","Sample Collection","Specimen Collection",{"type":14,"name":54,"description":55,"armGroupLabels":56,"otherNames":57},"Dietary Intervention","Adhere to a personalized diet",[39,40],[58,59,60,61,62],"Dietary Modification","intervention, dietary","Nutrition Intervention","Nutrition Interventions","Nutritional Interventions",{"type":14,"name":64,"description":65,"armGroupLabels":66,"otherNames":67},"Discussion","Participate in a focus group",[39,40],[68],"Discuss",{"type":14,"name":70,"description":71,"armGroupLabels":72},"Goal Setting","Set goals for behavioral changes",[40],{"type":14,"name":74,"description":75,"armGroupLabels":76},"Internet-Based Intervention","Complete self-paced web-based lifestyle program modules",[39,40],{"type":14,"name":78,"description":79,"armGroupLabels":80},"Medical Device Usage and Evaluation","Wear a physical activity tracker",[40],{"type":14,"name":82,"description":83,"armGroupLabels":84},"Questionnaire Administration","Ancillary studies",[39,40],{"type":14,"name":86,"description":87,"armGroupLabels":88,"otherNames":89},"Resistance Training","Participate in resistance training",[39,40],[90],"Strength Training",{"type":92,"name":93,"description":94,"armGroupLabels":95,"otherNames":96},"BEHAVIORAL","Smartphone Application-based Intervention","Receive access to the Fitbit app",[40],[97,98,99],"Smartphone App-based Intervention","Smartphone Intervention","Smartphone-based Intervention",{"type":14,"name":101,"description":102,"armGroupLabels":103,"otherNames":104},"Supportive Care","Receive access to online resources",[39,40],[105,106,107],"Supportive Therapy","Symptom Management","Therapy, Supportive",{"type":14,"name":101,"description":109,"armGroupLabels":110,"otherNames":111},"Attend virtual group sessions",[39],[105,106,107],{"type":44,"name":113,"description":114,"armGroupLabels":115},"Tailored Intervention","Receive JITAI tailored resource components",[40],[117,121,125,128,132,135,137,139],{"measure":118,"description":119,"timeFrame":120},"Preferences, needs and satisfaction (Aim 1a)","Focus groups will be audio recorded through online videoconference (e.g. Teams) and transcribed using NVivo. Content analysis will be conducted to identify patterns, themes, and perspectives from participants using NVivo coding or similar software. When possible, the frequency, intensity, and context of certain perspectives will be described. Similarly, thematic analysis will be conducted using NVivo to identify themes (e.g., likes\u002Fdislikes, motivations, expectations) and mapped to potential intervention components.","At pre- and post-intervention, assessed up to week 26",{"measure":122,"description":123,"timeFrame":124},"Percentage of early non-responders who complete the mobile Health + ecological momentary assessment intervention (Aim 1b)","Will report the frequency, proportion, and 95% confidence intervals (CIs) of early non-responders who completed the intervention.","Up to week 26",{"measure":126,"description":127,"timeFrame":124},"Percentage of all participants who complete all assessments (Aim 1c)","Will report the frequency, proportion, and 95% CIs of all participants who completed outcome assessments.",{"measure":129,"description":130,"timeFrame":131},"Changes in weight (Aim 2)","Linear mixed models will be used to account for repeated measures, with random effects for the individual. The linear mixed models will use all available data under a missing-at-random assumption and will assess potential attrition bias by comparing baseline\u002Fweek 4 characteristics of completers versus non-completers, with sensitivity analyses is missingness appears outcome-related. Will report the preliminary effect size as within-person changes on weight (from week 4 to week 26).","At baseline (T0), at week 4 (T1), and at week 26 (T2)",{"measure":133,"description":134,"timeFrame":131},"Changes in muscle mass (Aim 2)","Will estimate the preliminary effect size using linear mixed models.",{"measure":136,"description":134,"timeFrame":131},"Changes in metabolic profiles (Aim 2)",{"measure":138,"description":134,"timeFrame":131},"Changes in inflammatory markers (Aim 2)",{"measure":140,"description":134,"timeFrame":131},"Changes in behaviors (Aim 2)",[],"FEMALE","40 Years","69 Years",false,{"inclusion":147,"exclusion":160,"raw_text":165},[148,149,150,151,152,153,154,155,156,157,158,159],"Body mass index (BMI) ≥ 25kg\u002Fm\\^2","Age: 40-69 years","1-5 years post-diagnosis of stage I-III postmenopausal breast cancer or stage I-III endometrial cancer","No known evidence of recurrence (local or distant) or second, primary cancer","No prior history of new other malignancy since their breast or endometrial cancer diagnosis (other than non-melanoma skin cancer)","Not currently participating in any weight loss programs, no personal trainer, and not meeting the physical activity guidelines","No use of any anti-obesity medications in the last 6 months and no plan to start anti-obesity medications during the study period","The ability to walk two blocks without a walker or cane","The ability to speak and read English","Have access to internet with a computer, tablet, or smart phone","Live in rural counties in Ohio and not planning to move away during the study","Are not pregnant, breastfeeding or less than 12-month post-partum and do not plan to become pregnant during the study",[161,162,163,164],"Severe medical conditions, such as unstable cardiovascular disease or digestive disorders, that would preclude physical activity and dietary intervention","Lack of physician clearance if determined necessary by the Physical Activity Readiness Questionnaire (PAR-Q+)","Acute physical limitations for unsupervised exercises at home","Unable to give informed consent","Inclusion Criteria:\n\n* Body mass index (BMI) ≥ 25kg\u002Fm\\^2\n* Age: 40-69 years\n* 1-5 years post-diagnosis of stage I-III postmenopausal breast cancer or stage I-III endometrial cancer\n* No known evidence of recurrence (local or distant) or second, primary cancer\n* No prior history of new other malignancy since their breast or endometrial cancer diagnosis (other than non-melanoma skin cancer)\n* Not currently participating in any weight loss programs, no personal trainer, and not meeting the physical activity guidelines\n* No use of any anti-obesity medications in the last 6 months and no plan to start anti-obesity medications during the study period\n* The ability to walk two blocks without a walker or cane\n* The ability to speak and read English\n* Have access to internet with a computer, tablet, or smart phone\n* Live in rural counties in Ohio and not planning to move away during the study\n* Are not pregnant, breastfeeding or less than 12-month post-partum and do not plan to become pregnant during the study\n\nExclusion Criteria:\n\n* Severe medical conditions, such as unstable cardiovascular disease or digestive disorders, that would preclude physical activity and dietary intervention\n* Lack of physician clearance if determined necessary by the Physical Activity Readiness Questionnaire (PAR-Q+)\n* Acute physical limitations for unsupervised exercises at home\n* Unable to give informed consent",[167,168],"ADULT","OLDER_ADULT",[170],{"facility":13,"city":171,"state":172,"zip":173,"country":174,"contacts":175,"geoPoint":183},"Columbus","Ohio","43210","United States",[176,181],{"name":177,"role":178,"phone":179,"email":180},"Xiaochen Zhang, PhD","CONTACT","614-685-0624","Xiaochen.Zhang@osumc.edu",{"name":177,"role":182},"PRINCIPAL_INVESTIGATOR",{"lat":184,"lon":185},39.96118,-82.99879,[187],{"name":188,"role":178,"phone":189,"email":190},"The Ohio State University Comprehensive Cancer Center","800-293-5066","OSUCCCClinicaltrials@osumc.edu",[192],{"name":177,"affiliation":13,"role":182},[],[195],{"label":196,"url":197},"The Jamesline","http:\u002F\u002Fcancer.osu.edu",{"nct_id":4,"conditions":199,"biomarkers":201},[200,22],"Breast Carcinoma",[],{"nct_id":4,"found":15,"summary":203,"prompt_version":213},{"design":204,"status":205,"heading":206,"summary":207,"follow_up":208,"word_count":209,"commitments":210,"compensation":211,"drugs_mentioned":212},"This interventional study plans to enroll 90 women. It will test an adaptive, online program that includes a web-based lifestyle program, mHealth, and ecological momentary assessment (EMA) intervention.","completed","Web-based Lifestyle Program for Breast and Endometrial Cancer Survivors","This study, called the HERO-C Trial, is for women aged 40-69 who have had stage I-III postmenopausal breast cancer or stage I-III endometrial cancer within the last 1-5 years and have a BMI of 25 or higher. It aims to understand the needs of rural cancer survivors and test an online program that includes a web-based lifestyle program, mobile health (mHealth) tools, and ecological momentary assessment (EMA) to help with weight loss. Participants will follow a personalized diet and do moderate-intensity aerobic exercise. The main goals are to see how satisfied participants are with the program and how many complete the interventions and assessments. This research hopes to improve lifestyle changes and weight loss efforts for cancer survivors.","The primary endpoints, including preferences, needs, satisfaction, and completion rates, are measured at pre- and post-intervention, assessed up to week 26.",118,"You would participate in a web-based lifestyle program, follow a personalized diet, and do aerobic exercise. You would also provide urine and blood samples, participate in focus groups, and set behavioral goals, with assessments up to week 26.","Not stated in the trial record.",[36],"v2"]